FDA Adverse Event Other Summary report: N

MITROFLOW AORTIC PERICARDIAL HEART VALVE

MDR report key: 2379122 · Received December 8, 2011

Report

Report Number
3004478276-2011-00013
Event Type
Other
Date Received
December 8, 2011
Date of Event
November 6, 2011
Report Date
December 8, 2011
Manufacturer
SORIN GROUP CANADA INC. MITROFLOW DIVISION
Product Code
LWR
PMA / PMN Number
P060038
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OR, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS RECEIVED ON (B)(6) 2011, BUT AN EVALUATION SUMMARY IS NOT AVAILABLE AT THIS TIME. GROSS EXAMINATION INDICATED LEAFLET CALCIFICATION AND PANNUS FORMATION ON THE SEWING RING AND LEAFLETS. X-RAY ANALYSIS CONFIRMED THE PRESENCE OF CALCIFICATION. FULL MORPHO-HISTOLOGICAL ANALYSIS IS IN PROGRESS. METHOD - A REVIEW OF THE DEVICE HISTORY RECORD WAS COMPLETED. RESULT - THE RESULTS OF THE DEVICE HISTORY RECORD REVIEW CONFIRMED THE DEVICE MET ALL MATERIAL, DIMENSIONAL, AND PERFORMANCE REQUIREMENTS AT THE TIME OF MFR AND RELEASE. CONCLUSION: NO CONCLUSION CAN BE DRAWN AT THIS TIME AS DEVICE EVAL, INCLUDING HISTOPATHOLOGY, IS IN PROGRESS.

Description of Event or Problem · 1

SORIN GROUP (B)(4) INC., MITROFLOW DIVISION WAS NOTIFIED ON (B)(6) 2011 OF A MITROFLOW VALVE (MODEL 12A27; S/N (B)(4)) THAT WAS EXPLANTED ON (B)(6) 2011 FOR REPORTED CENTRAL AORTIC REGURGITATION. THE VALVE WAS IMPLANTED ON (B)(6) 2004 AS PART OF THE (B)(6) STUDY. AS REPORTED, THE MITROFLOW VALVE WAS EXPLANTED AND WAS REPLACED WITH AN EDWARDS LIFESCIENCES MAGNA EASE BIOPROSTHETIC AORTIC VALVE, SIZE 29 MM. REPORTEDLY, THE PT EXPERIENCED A POST-OPERATIVE CARDIO-EMBOLIC INDUCED CVA ON (B)(6) 2011. ACCORDING TO THE FIELD EXPERIENCE REPORT FORM, THE ATTENDING SURGEON IS NOT EXPRESSING A COMPLAINT WITH THE QUALITY AND/OR PERFORMANCE OF THE MITROFLOW VALVE. THE EVENT WAS REPORTED TO THE COMPANY AS PART OF THE ONGOING MITROFLOW LONG-TERM CLINICAL STUDY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 MITROFLOW AORTIC PERICARDIAL HEART VALVE TISSUE, HEART VALVE LWR SORIN GROUP CANADA INC. MITROFLOW DIVISION 12A NA

Patients

Seq Age Sex Outcome Treatment
1 71 YR Required Intervention